Evidence map›Paper›PMID 23474283›Full record

Trial reportGastroenterology2013

Consumption of fermented milk product with probiotic modulates brain activity.

Kirsten Tillisch, Jennifer Labus, Lisa Kilpatrick, Zhiguo Jiang, Jean Stains, Bahar Ebrat, Denis Guyonnet, Sophie Legrain-Raspaud, Beatrice Trotin, Bruce Naliboff and 1 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 481 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
481citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03494725 nacompletednot on this mapstarted 2018, after this paper: background citation

Proof-of-Concept "Stress & Anxiety Dampening Effects of Lpc-37"

TypeinterventionalSponsorDaacroRan2018 to 2018Enrolled120ConditionsHealthy, Stress, PsychologicalArmsLpc-37, Placebo
NCT05943925 unknown statusnot on this mapstarted 2021, after this paper: background citation

Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?

TypeobservationalSponsorUniversity Rovira i VirgiliRan2021 to 2025Enrolled240ConditionsDementia Alzheimers, Dementia With Lewy Bodies, Parkinson Disease Dementia, Dementia FrontotemporalArmsNo intervention, Probiotic supplement
3 · Its place in the literature

Who cites it

481 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Efficacy and Safety ofNutrients · 2025
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. ProbioticNutrients · 2022
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Effects ofNutrients · 2021
    Trial

421 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kirsten TillischOppenheimer Family Center for Neurobiology of Stress, Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. ktillisch@mednet.ucla.edu
Jennifer Labus
Lisa Kilpatrick
Zhiguo Jiang
Jean Stains
Bahar Ebrat
Denis Guyonnet
Sophie Legrain-Raspaud
Beatrice Trotin
Bruce Naliboff
Emeran A Mayer

Funding

PERCEPTION AND MODULATION OF VISCERAL SENSATIONSR01DK048351 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 1996 to 2019
$8.2M
Sex-specific genetic architecture of irritable bowel syndromeK01DK085133 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KILPATRICK, LISA A · 2011 to 2015
$640k
NIDDK NIH HHS K01 DK085133NIDDK NIH HHS R01 DK048351
6 · The paper itself

Abstract

BACKGROUND &

aimsChanges in gut microbiota have been reported to alter signaling mechanisms, emotional behavior, and visceral nociceptive reflexes in rodents. However, alteration of the intestinal microbiota with antibiotics or probiotics has not been shown to produce these changes in humans. We investigated whether consumption of a fermented milk product with probiotic (FMPP) for 4 weeks by healthy women altered brain intrinsic connectivity or responses to emotional attention tasks.

methodsHealthy women with no gastrointestinal or psychiatric symptoms were randomly assigned to groups given FMPP (n = 12), a nonfermented milk product (n = 11, controls), or no intervention (n = 13) twice daily for 4 weeks. The FMPP contained Bifidobacterium animalis subsp Lactis, Streptococcus thermophiles, Lactobacillus bulgaricus, and Lactococcus lactis subsp Lactis. Participants underwent functional magnetic resonance imaging before and after the intervention to measure brain response to an emotional faces attention task and resting brain activity. Multivariate and region of interest analyses were performed.

resultsFMPP intake was associated with reduced task-related response of a distributed functional network (49% cross-block covariance; P = .004) containing affective, viscerosensory, and somatosensory cortices. Alterations in intrinsic activity of resting brain indicated that ingestion of FMPP was associated with changes in midbrain connectivity, which could explain the observed differences in activity during the task.

conclusionsFour-week intake of an FMPP by healthy women affected activity of brain regions that control central processing of emotion and sensation.

Indexed as

Cultured Milk ProductsProbioticsAdolescentAdultAttentionBifidobacteriumBrainFemaleFunctional NeuroimagingHumansLactobacillusLactococcus lactisMagnetic Resonance ImagingMiddle AgedStreptococcus thermophilusTreatment Outcome

Identifiers

PMID23474283
PMCPMC3839572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.